According to the NHS England guidance16 on the implementation of Libre glucose monitoring prescribing across the NHS in London, patients with any form of diabetes undergoing haemodialysis and receiving insulin treatment are eligible for Libre glucose monitoring. The gene discussed is INS; the disease is diabetes mellitus.